Trial · NCT02460458
Outcomes14
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
1 to 14 of 14
Download this page as JSON| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Centralized Factor VIII (FVIII) Procoagulant Activity (FVIII:C) Laboratory Test for Type 3 Von Willebrand's Disease (VWD3) Diagnosis | 12 months (confirmatory phase) | Factor VIII (FVIII) Procoagulant Activity (FVIII:C) was centrally obtained from samples collected from investigational sites. | IU/dL | MEAN |
| PRIMARY | Centralized Von Willebrand Factor Antigen (VWF:Ag) Laboratory Test for Type 3 Von Willebrand's Disease (VWD3) Diagnosis | 12 months (confirmatory phase) | Von Willebrand Factor (VWF) protein blood levels were centrally obtained from samples collected from investigational sites. | IU/dL | MEAN |
| PRIMARY | Centralized Factor VIII (FVIII) Amidolytic Activity (FVIII:Am) Laboratory Test for Type 3 Von Willebrand's Disease (VWD3) Diagnosis | 12 months (confirmatory phase) | Factor VIII (FVIII) Amidolytic Activity (FVIII:Am) in the blood was centrally obtained from samples collected from investigational sites. | IU/dL | MEAN |
| PRIMARY | Centralized Factor VIII (FVIII) Antigen (FVIII:Ag) Laboratory Test for Type 3 Von Willebrand's Disease (VWD3) Diagnosis | 12 months (confirmatory phase) | Factor VIII (FVIII) protein blood levels were centrally obtained from samples collected from investigational sites. | IU/dL | MEAN |
| PRIMARY | Centralized Von Willebrand Factor (VWF) Multimer Analysis for Type 3 Von Willebrand's Disease (VWD3) Diagnosis | 12 months (confirmatory phase) | Von Willebrand Factor (VWF) multimer profiles of patients were centrally obtained from samples collected from investigational sites. | Participants | COUNT_OF_PARTICIPANTS |
| PRIMARY | Centralized Von Willebrand Factor (VWF) Propeptide Laboratory Test for Type 3 Von Willebrand's Disease (VWD3) Diagnosis | 12 months (confirmatory phase) | Von Willebrand Factor (VWF) Propeptide blood levels were centrally obtained from samples collected from investigational sites. | IU/dL | MEAN |
| PRIMARY | Centralized Molecular Type 3 Von Willebrand's Disease (VWD3) Diagnosis Through DNA Analysis | 12 months (confirmatory phase) | Samples were not available for 34 patients out of 265 | Participants | COUNT_OF_PARTICIPANTS |
| PRIMARY | Record of Bleeding Episodes | 24 months (first prospective phase) + 24 months (second prospective phase) | Patients that have competed both prospective phases. | bleeding episodes | NUMBER |
| PRIMARY | Adverse Events | 24 months (first prospective phase) + 24 months (second prospective phase) | Patients that have competed both prospective phases. | AE | NUMBER |
| PRIMARY | Type of Von Willebrand Factor / Factor VIII (VWF/FVIII)-Containing Concentrates in Use | 24 months (first prospective phase) + 24 months (second prospective phase) | Patients that have competed both prospective phases. | participants | NUMBER |
| SECONDARY | Patients Experiencing Allergic Reactions During Use of Von Willebrand Factor (VWF)-Containing Concentrates | 24 months (retrospective phase) | Participants | COUNT_OF_PARTICIPANTS | |
| SECONDARY | Number of Participants With Previous Use of Blood Products | 24 months (retrospective phase) | Participants | COUNT_OF_PARTICIPANTS | |
| SECONDARY | Number of Patients With Available Local Laboratory Test for Anti-Von Willebrand Factor (Anti-VWF) Antibodies | 24 months (retrospective phase) | Participants | COUNT_OF_PARTICIPANTS | |
| SECONDARY | Local Laboratory Tests for Type 3 Von Willebrand's Disease (VWD3) Diagnosis (Composite) | 24 months (retrospective phase) | Participants | COUNT_OF_PARTICIPANTS |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02460458/outcomes